1. OnabotulinumtoxinA for chronic migraine in Korea: 1-month postmarketing surveillance and phase 4 trial results. (25th December 2016) Authors: Kim, ByungKun; Kim, Manho; Chung, Chin-Sang; DeGryse, Ronald; Lai, Karen; Yushmanova, Irina; Lum, Arlene; Davar, Gudarz Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Real-world treatment utilization and safety of onabotulinumtoxinA for chronic migraine from an observational study in the European union. (25th December 2016) Authors: Matharu, Manjit; Pascual, Julio; Remahl, Ingela Nilsson; Straube, Andreas; Lum, Arlene; Davar, Gudarz; Odom, Dawn; Bennett, Lee; Proctor, Christina; Gutierrez, Lia; Andrews, Elizabeth; Johannes, Catherine Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Utilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine from an observational study in Europe. (December 2017) Authors: Matharu, Manjit; Pascual, Julio; Nilsson Remahl, Ingela; Straube, Andreas; Lum, Arlene; Davar, Gudarz; Odom, Dawn; Bennett, Lee; Proctor, Christina; Gutierrez, Lia; Andrews, Elizabeth; Johannes, Catherine Journal: Cephalalgia Issue: Volume 37:Number 14(2017) Page Start: 1384 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗